Cargando…
Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations
Anaphylaxis, a type 1 hypersensitivity reaction, is a feared but uncommon complication of medications administered in the perioperative period. The incidence of perioperative hypersensitivity reactions has been reported to range from 1 in 20,000 to 1 in 1,361. Anesthesiologists are well aware of com...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522439/ https://www.ncbi.nlm.nih.gov/pubmed/37767049 http://dx.doi.org/10.1155/2023/3873076 |
_version_ | 1785110355312115712 |
---|---|
author | Winegarner, Andrew Kendall, Mark C. Stephen, Mekhala Siddiqui, Afreen |
author_facet | Winegarner, Andrew Kendall, Mark C. Stephen, Mekhala Siddiqui, Afreen |
author_sort | Winegarner, Andrew |
collection | PubMed |
description | Anaphylaxis, a type 1 hypersensitivity reaction, is a feared but uncommon complication of medications administered in the perioperative period. The incidence of perioperative hypersensitivity reactions has been reported to range from 1 in 20,000 to 1 in 1,361. Anesthesiologists are well aware of common causes of hypersensitivity such as paralytics and antibiotics; however, less common triggers of anaphylaxis need to be considered as well. Midazolam, a short acting benzodiazepine metabolized by cytochrome P450 enzymes, is considered very safe with a minimal risk profile. Previous reports have described adverse reactions to occur within seconds to minutes following the administration of midazolam. We describe a patient with no known history of asthma or allergies who underwent elective hydrocelectomy with spinal analgesia without incident until 42 minutes later at the conclusion of the procedure, when they experienced circulatory collapse necessitating immediate emergency treatment. This case emphasizes the necessity to improve knowledge and awareness of delayed hypersensitivity reactions following the administration of perioperative medications such as midazolam. |
format | Online Article Text |
id | pubmed-10522439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-105224392023-09-27 Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations Winegarner, Andrew Kendall, Mark C. Stephen, Mekhala Siddiqui, Afreen Case Rep Anesthesiol Case Report Anaphylaxis, a type 1 hypersensitivity reaction, is a feared but uncommon complication of medications administered in the perioperative period. The incidence of perioperative hypersensitivity reactions has been reported to range from 1 in 20,000 to 1 in 1,361. Anesthesiologists are well aware of common causes of hypersensitivity such as paralytics and antibiotics; however, less common triggers of anaphylaxis need to be considered as well. Midazolam, a short acting benzodiazepine metabolized by cytochrome P450 enzymes, is considered very safe with a minimal risk profile. Previous reports have described adverse reactions to occur within seconds to minutes following the administration of midazolam. We describe a patient with no known history of asthma or allergies who underwent elective hydrocelectomy with spinal analgesia without incident until 42 minutes later at the conclusion of the procedure, when they experienced circulatory collapse necessitating immediate emergency treatment. This case emphasizes the necessity to improve knowledge and awareness of delayed hypersensitivity reactions following the administration of perioperative medications such as midazolam. Hindawi 2023-09-19 /pmc/articles/PMC10522439/ /pubmed/37767049 http://dx.doi.org/10.1155/2023/3873076 Text en Copyright © 2023 Andrew Winegarner et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Winegarner, Andrew Kendall, Mark C. Stephen, Mekhala Siddiqui, Afreen Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations |
title | Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations |
title_full | Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations |
title_fullStr | Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations |
title_full_unstemmed | Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations |
title_short | Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations |
title_sort | delayed anaphylactic reaction to midazolam in the absence of immediate respiratory or skin manifestations |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522439/ https://www.ncbi.nlm.nih.gov/pubmed/37767049 http://dx.doi.org/10.1155/2023/3873076 |
work_keys_str_mv | AT winegarnerandrew delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations AT kendallmarkc delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations AT stephenmekhala delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations AT siddiquiafreen delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations |